Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy?

CAW Rijcken*, JAM Dekens-Konter, H Knegtering, LTW de Jong-van den Berg

*Corresponding author for this work

    Research output: Contribution to journalEditorialAcademicpeer-review

    3 Citations (Scopus)

    Abstract

    Sexual function disorders are frequent adverse effects of antipsychotic use. These effects can lead to non-compliance to medication, which dramatically worsen the outcome of the psychotic disease. Detecting sexual dysfunction by the carers may be difficult, since feelings of embarrassment may occur in both care-taker as in patient. In order to prevent underreporting, strategies to recognise sexual dysfunction should be developed, based upon collaboration between care providers of the psychotic patient. Community pharmacies in many countries can detect non-compliance to medication in prescription data and report this to psychiatric services of the patient. Exchanging information by cross-sectoral networks may optimise the disease management of the psychotic patient.

    Original languageEnglish
    Pages (from-to)169-172
    Number of pages4
    JournalPharmacy World & Science
    Volume23
    Issue number5
    Publication statusPublished - 2001

    Keywords

    • antipsychotic drug
    • adverse effect
    • sexual disorders
    • compliance
    • PROLACTIN LEVELS
    • DYSFUNCTION
    • MEDICATIONS

    Fingerprint

    Dive into the research topics of 'Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy?'. Together they form a unique fingerprint.

    Cite this